Alicon Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 7.50 M
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 29.50 Cr
- Satisfied Charges ₹ 7.84 Cr
- Revenue Growth -33.39%
- Profit Growth -45.70%
- Ebitda -52.11%
- Net Worth 15.47%
- Total Assets 19.67%
About Alicon Pharmaceutical
Alicon Pharmaceutical Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 March 1995 and has a history of 29 years and 11 months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹29.50 Cr. The company has closed loans amounting to ₹7.84 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nitinbhai Savani, Chandan Soni, Ashish Singh, and Three other members serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U99999MH1995PTC086137
-
Company No.
086137
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Mar 1995
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Alicon Pharmaceutical?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandan Soni
|
Director | 16-Feb-2018 | Current |
|
Nitinbhai Savani
|
Director | 22-Oct-2018 | Current |
|
Ashish Singh
|
Director | 01-Feb-2020 | Current |
|
Anup Tapadiya
|
Director | 22-Oct-2018 | Current |
|
Priyank Savani
|
Director | 16-Feb-2018 | Current |
|
Mayuri Savani
|
Director | 21-Mar-2022 | Current |
Financial Performance of Alicon Pharmaceutical.
Alicon Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.39% decrease. The company also saw a substantial fall in profitability, with a 45.7% decrease in profit. The company's net worth Soared by an impressive increase of 15.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alicon Pharmaceutical?
Unlock access to Alicon Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Tapadiya Interventional Technologies & H Ealthcare LlpAnup Tapadiya is a mutual person
-
Gripil Pharmaceuticals Private LimitedChandan Soni is a mutual person
-
Kiran Wind Energy Private LimitedNitinbhai Savani is a mutual person
-
Satvam Pharma Private LimitedChandan Soni, Anup Tapadiya and 1 more are mutual person
-
Vitalta Lifetech Private Limited
Anup Tapadiya is a mutual person
-
Gangaveda Private Limited
Mayuri Savani is a mutual person
Charges (Loans)
₹295.00 M
₹78.43 M
Charges Breakdown by Lending Institutions
- Bank Of India : 20.00 Cr
- Others : 9.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2024 | Bank Of India | ₹20.00 Cr | Open |
| 11 Sep 2019 | Others | ₹5.00 M | Open |
| 20 Dec 2018 | Others | ₹5.00 Cr | Open |
| 20 Dec 2018 | Others | ₹4.00 Cr | Open |
| 16 Jul 2014 | Union Bank Of India | ₹8.25 M | Satisfied |
How Many Employees Work at Alicon Pharmaceutical?
Alicon Pharmaceutical has a workforce of 57 employees as of Jan 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alicon Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alicon Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
